HKEX: 6618 - JD Health International Inc.

Yield per half year: -5.59%
Sector: Healthcare

JD Health International Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
50.4 35.42 42.32% 66.52 -24.23%
P/S 2.02 7.59 -73.42%
P/BV 2.19 3.68 -40.66%
P/FCF 35.72 55.41 -35.53%
Ev/Ebitda 133.36 2.91 4486.14%
Ev/S 2.11 23.72 -91.12%
Ev/FCF 24.86 63.79 -61.02%
E/P 0.0132 0.0326 -59.52%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
1.81 -11.9 -115.21% -18.53 -109.77%
ROE 4.55 5.19 -12.26%
ROA 3.41 3.47 -1.67%
ROIC 0 0 0%
ROS 4 -11.49 -134.82%
ROCE 0 6.04 -100%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.2358 0.7755 -69.59% -1.82 -112.94%
Nеt Debt/Ebitda 0 0.0128 -100%
Debt/Ratio 0.0031 0.1229 -97.48%
Debt/Equity 0.283 0.8001 -64.63%
Debt/Net Income 0.0931 1.76 -94.7%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.42 -100% 0 0%
Number of years of dividend growth 0 1.21 -100%
DSI 0 0.563 -100%
Average dividend growth 0 3.2 -100%
Average percentage for 5 years 0 1.82 -100%
Average percentage for payments 0 23.96 -100%
Difference from average difference in sector -2.42
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
10/10
393.72 19.4 1929.48%
Growth impulse Ebitda 5 years 170.46 -44.8 -480.49%
Growth impulse Net Income 5 years -320.4 80.79 -496.58%
Growth impulse FCF 5 years 1023.24 76.43 1238.79%
Growth impulse EPS 5 years -1915.16 -116.84 1539.13%
IP Score
4.53/10

Similar companies

Sino Biopharmaceutical Limited

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co. Ltd.

Hansoh Pharmaceutical Group Company Limited